Related Experiment Videos
Recent advances with liposomes as pharmaceutical carriers
1Department of Pharmaceutical Sciences, Northeastern University, 360 Huntington Avenue, Boston, Massachusetts 02115, USA. v.torchilin@neu.edu
Nature Reviews. Drug Discovery
|February 3, 2005
Summary
Liposomes, phospholipid vesicles, show great pharmaceutical potential, especially in gene delivery and cancer therapy. Future development requires identifying promising trends while understanding current limitations.
Area of Science:
- Nanotechnology
- Materials Science
- Pharmaceutical Sciences
Background:
- Liposomes, microscopic phospholipid vesicles with bilayered membranes, have been investigated for 30 years as drug carriers.
- Significant advancements in liposomal drug development have emerged, including clinical approvals and experimental applications.
Purpose of the Study:
- To review recent developments in liposomal drug delivery systems.
- To identify promising future trends in liposome research.
- To acknowledge the limitations of current liposomal approaches.
Main Methods:
- Literature review of recent advancements in liposomal drug delivery.
- Analysis of clinical and experimental applications of liposomes.
- Identification of emerging trends and challenges in the field.
Main Results:
- Liposomes are established as potent pharmaceutical carriers with diverse applications.
- Gene delivery and cancer therapy remain primary research areas for liposomal applications.
- New experimental applications and clinically approved products highlight ongoing progress.
Conclusions:
- Continued progress in liposomal drug development necessitates strategic identification and exploitation of promising trends.
- A clear understanding of the limitations associated with liposomal drug delivery is crucial for future success.
- Further research should focus on overcoming existing challenges to fully realize the potential of liposomes.